Should Direct Thrombin Inhibitors be the Anticoagulant of Choice for Patients on Extracorporeal Membrane Oxygenation?: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Publication | Program = Critical Care | Year = 2020 | Primary Author = H Muller Moran | Other Authors = R Eikelboom, R Adriano, R Manji | PubType = Abstract | Journal = |..." |
No edit summary |
||
| Line 2: | Line 2: | ||
| Program = Critical Care | | Program = Critical Care | ||
| Year = 2020 | | Year = 2020 | ||
| Primary Author = H Muller Moran | | Primary Author =H Muller Moran | ||
| Other Authors = | | Other Authors =R Eikelboom, R Adriano, R Manji | ||
| PubType = | | PubType = Abstract | ||
| Journal = | | Journal = Canadian Journal of Cardiology | ||
| GoogleScholarLink = | | GoogleScholarLink = | ||
| PubMedLink = | | PubMedLink = | ||
Revision as of 11:34, 26 April 2021
| Publication | |
| Publication: | Should Direct Thrombin Inhibitors be the Anticoagulant of Choice for Patients on Extracorporeal Membrane Oxygenation? |
| Year: | 2020 |
| Authors: | H Muller Moran, R Eikelboom, R Adriano, R Manji |
| Publication Type: | Abstract |
| Journal: | Canadian Journal of Cardiology |
| No DOI link available, alternate link: | |
| Program: | Critical Care |
| Through MCHP: | no |